Helmerich & Payne Inc. (NYSE:HP): Jefferies has downgraded the company to Hold from Buy due to lower U.S. rig count forecasts and dayrate risk. The firm also lowered its price target for shares to $71 from $74.
Inovio Pharmaceuticals Inc. (AMEX:INO): Maxim has brought its price on Inovio to $2 from $1 based on clinical progress the company has made. The firm notes that the company’s vaccines for the H7N9 and H1N1 viruses have generated positive data, and keeps a Buy rating on the stock.
Exact Sciences Corp. (NASDAQ:EXAS): Maxim sees reimbursement rate risk for Exact Sciences’ Cologuard following Monday night’s release of the proposed physician fee schedule for Medicare, and believes Exact Sciences is unlikely to achieve an average selling price of $500 given the CMS’s proposed review of all laboratory test reimbursement rates. Maxim recommends selling shares of Exact Sciences.
Applied Materials Inc. (NASDAQ:AMAT): Stifel sees the company’s outlook as being positive after attending Applied Materials’s Analyst Day. The firm expects the company to benefit from its new products, the increased complexity of semiconductor development, and strength in its flat panel business. The firm was pleased by the company’s guidance and keeps a Buy rating on the shares.